L. R. Shore, The lymphatic drainage of the human heart, J Anat, vol.63, issue.3, pp.291-313, 1929.

R. R. Bradham, E. F. Parker, B. A. Barrington, C. M. Webb, and J. M. Stallworth, The cardiac lymphatics, Ann Surg, vol.171, pp.899-902, 1970.

A. J. Miller, The grossly invisible and generally ignored lymphatics of the mammalian heart, Med Hypotheses, vol.76, pp.604-606, 2011.

J. R. Levick and C. C. Michel, Microvascular fluid exchange and the revised Starling principle, Cardiovasc Res, vol.87, 2010.

I. K. Kline, A. J. Miller, and L. N. Katz, Cardiac lymph flow impairment and myocardial fibrosis. Effects of chronic obstruction in dogs, Arch Pathol, vol.76, pp.424-433, 1963.

L. L. Ludwig, E. R. Schertel, J. W. Pratt, D. E. Mcclure, A. J. Ying et al., Impairment of left ventricular function by acute cardiac lymphatic obstruction, Cardiovasc Res, vol.33, pp.164-171, 1997.

Y. Cui, The role of lymphatic vessels in the heart, Pathophysiology, vol.17, pp.307-314, 2010.

U. Mehlhorn, H. J. Geissler, G. A. Laine, and S. J. Allen, Myocardial fluid balance, Eur J Cardiothorac Surg, vol.20, pp.1220-1230, 2001.

J. Li, L. F. Brown, M. G. Hibberd, J. D. Grossman, J. P. Morgan et al., VEGF, flk-1, and flt-1 expression in a rat myocardial infarction model of angiogenesis, Am J Physiol, vol.270, issue.5, pp.1803-1811, 1996.

S. Weis, S. Shintani, A. Weber, R. Kirchmair, M. Wood et al.,

D. and C. D. , Src blockade stabilizes a Flk/cadherin complex, reducing edema and tissue injury following myocardial infarction, J Clin Invest, vol.113, pp.885-894, 2004.

S. M. Weis and D. A. Cheresh, Pathophysiological consequences of VEGFinduced vascular permeability, Nature, vol.437, pp.497-504, 2005.

M. Nahrendorf, F. K. Swirski, E. Aikawa, L. Stangenberg, T. Wurdinger et al., The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions, J Exp Med, vol.204, pp.3037-3047, 2007.

V. Barbay, M. Houssari, M. Mekki, S. Banquet, F. Edwards-lévy et al., Role of M2-like macrophage recruitment during angiogenic growth factor therapy, Angiogenesis, vol.18, pp.191-200, 2015.

D. L. Mann, Inflammatory mediators and the failing heart: past, present, and the foreseeable future, Circ Res, vol.91, pp.988-998, 2002.

D. C. Zawieja, S. T. Greiner, K. L. Davis, W. M. Hinds, and H. J. Granger, Reactive oxygen metabolites inhibit spontaneous lymphatic contractions, Am J Physiol, vol.260, issue.6, pp.1935-1943, 1991.

M. B. Aldrich and E. M. Sevick-muraca, Cytokines are systemic effectors of lymphatic function in acute inflammation, Cytokine, vol.64, pp.362-369, 2013.

J. C. Nilsson, G. Nielsen, B. A. Groenning, T. Fritz-hansen, L. Sondergaard et al., Sustained postinfarction myocardial oedema in humans visualised by magnetic resonance imaging, Heart, vol.85, pp.639-642, 2001.

A. Manrique, E. Gerbaud, G. Derumeaux, A. Cribier, D. Bertrand et al., Cardiac magnetic resonance demonstrates myocardial oedema in remote tissue early after reperfused myocardial infarction, Arch Cardiovasc Dis, vol.102, pp.633-639, 2009.
URL : https://hal.archives-ouvertes.fr/inserm-00467140

K. Alitalo and P. Carmeliet, Molecular mechanisms of lymphangiogenesis in health and disease, Cancer Cell, vol.1, pp.219-227, 2002.

K. Alitalo, The lymphatic vasculature in disease, Nat Med, vol.17, 2011.

W. Zheng, A. Aspelund, and K. Alitalo, Lymphangiogenic factors, mechanisms, and applications, J Clin Invest, vol.124, pp.878-887, 2014.

A. Dashkevich, W. Bloch, A. Antonyan, J. U. Fries, and H. J. Geissler, Morphological and quantitative changes of the initial myocardial lymphatics in terminal heart failure, Lymphat Res Biol, vol.7, pp.21-27, 2009.

I. Kholova, G. Dragneva, P. Cermakova, S. Laidinen, N. Kaskenpaa et al., Lymphatic vasculature is increased in heart valves, ischaemic and inflamed hearts and in cholesterol-rich and calcified atherosclerotic lesions, Eur J Clin Invest, vol.41, pp.487-497, 2010.

C. Norrmén, T. Tammela, T. V. Petrova, and K. Alitalo, Biological basis of therapeutic lymphangiogenesis, Circulation, vol.123, pp.1335-1351, 2011.

R. Huggenberger, S. Ullmann, S. T. Proulx, B. Pytowski, K. Alitalo et al., Stimulation of lymphangiogenesis via VEGFR-3 inhibits chronic skin inflammation, J Exp Med, vol.207, pp.2255-2269, 2010.

M. Lähteenvuo, K. Honkonen, T. Tervala, T. Tammela, E. Suominen et al., Growth factor therapy and autologous lymph node transfer in lymphedema, Circulation, vol.123, pp.613-620, 2011.

S. Banquet, E. Gomez, L. Nicol, F. Edwards-lévy, J. P. Henry et al., Arteriogenic therapy by intramyocardial sustained delivery of a novel growth factor combination prevents chronic heart failure, Circulation, vol.124, pp.1059-1069, 2011.

P. Mulder, S. Barbier, A. Chagraoui, V. Richard, J. P. Henry et al., Long-term heart rate reduction induced by the selective I(f) current inhibitor ivabradine improves left ventricular function and intrinsic myocardial structure in congestive heart failure, Circulation, vol.109, pp.1674-1679, 2004.

Z. Luo, M. Diaco, T. Murohara, N. Ferrara, J. M. Isner et al., Vascular endothelial growth factor attenuates myocardial ischemia-reperfusion injury, Ann Thorac Surg, vol.64, pp.993-998, 1997.

A. Ratajska, G. Gula, A. Flaht-zabost, E. Czarnowska, B. Ciszek et al., Comparative and developmental anatomy of cardiac lymphatics, ScientificWorldJournal, p.183170, 2014.

R. P. Kataru, K. Jung, C. Jang, H. Yang, R. A. Schwendener et al., Critical role of CD11b+ macrophages and VEGF in inflammatory lymphangiogenesis, antigen clearance, and inflammation resolution, Blood, vol.113, pp.5650-5659, 2009.

H. Wiig, A. Schröder, W. Neuhofer, J. Jantsch, C. Kopp et al., Immune cells control skin lymphatic electrolyte homeostasis and blood pressure, J Clin Invest, vol.123, pp.2803-2815, 2013.

V. Joukov, V. Kumar, T. Sorsa, E. Arighi, H. Weich et al., A recombinant mutant vascular endothelial growth factor-C that has lost vascular endothelial growth factor receptor-2 binding, activation, and vascular permeability activities, J Biol Chem, vol.273, pp.6599-6602, 1998.

J. B. Burton, M. Johnson, M. Sato, S. B. Koh, D. J. Mulholland et al., Adenovirus-mediated gene expression imaging to directly detect sentinel lymph node metastasis of prostate cancer, Nat Med, vol.14, pp.882-888, 2008.

A. I. Nykänen, H. Sandelin, R. Krebs, M. A. Keränen, R. Tuuminen et al., Targeting lymphatic vessel activation and CCL21 production by vascular endothelial growth factor receptor-3 inhibition has novel immunomodulatory and antiarteriosclerotic effects in cardiac allografts, Circulation, vol.121, pp.1413-1422, 2010.

K. L. Davis, G. A. Laine, H. J. Geissler, U. Mehlhorn, M. Brennan et al., Effects of myocardial edema on the development of myocardial interstitial fibrosis, Microcirculation, vol.7, pp.269-280, 2000.

H. Moriwaki, A. Stempien-otero, M. Kremen, A. E. Cozen, and D. A. Dichek, Overexpression of urokinase by macrophages or deficiency of plasminogen activator inhibitor type 1 causes cardiac fibrosis in mice, Circ Res, vol.95, pp.637-644, 2004.

C. S. Mckimmie, M. D. Singh, K. Hewit, O. Lopez-franco, L. Brocq et al., An analysis of the function and expression of D6 on lymphatic endothelial cells, Blood, vol.121, pp.3768-3777, 2013.

Y. Ishikawa, Y. Akishima-fukasawa, K. Ito, Y. Akasaka, M. Tanaka et al., Lymphangiogenesis in myocardial remodelling after infarction, Histopathology, vol.51, pp.345-353, 2007.

Q. N. Sun, Y. F. Wang, and Z. K. Guo, Reconstitution of myocardial lymphatic vessels after acute infarction of rat heart, Lymphology, vol.45, pp.80-86, 2012.

L. Klotz, S. Norman, J. M. Vieira, M. Masters, M. Rohling et al., Cardiac lymphatics are heterogeneous in origin and respond to injury, Nature, vol.522, pp.62-67, 2015.

G. A. Laine and S. J. Allen, Left ventricular myocardial edema. Lymph flow, interstitial fibrosis, and cardiac function, Circ Res, vol.68, pp.1713-1721, 1991.

R. M. Dongaonkar, R. H. Stewart, H. J. Geissler, and G. A. Laine, Myocardial microvascular permeability, interstitial oedema, and compromised cardiac function, Cardiovasc Res, vol.87, pp.331-339, 2010.

N. Wick, D. Haluza, E. Gurnhofer, I. Raab, M. T. Kasimir et al., Lymphatic precollectors contain a novel, specialized subpopulation of podoplanin low, CCL27-expressing lymphatic endothelial cells, Am J Pathol, vol.173, pp.1202-1209, 2008.

S. Lutter, S. Xie, F. Tatin, and T. Makinen, Smooth muscle-endothelial cell communication activates Reelin signaling and regulates lymphatic vessel formation, J Cell Biol, vol.197, pp.837-849, 2012.

A. Taira, Y. Morishita, K. Arikawa, K. Murata, Y. Hamada et al., Flow velocity of cardiac lymph and contractility of the heart: an experimental study, Ann Thorac Surg, vol.23, pp.230-234, 1977.

U. Mehlhorn, K. L. Davis, E. J. Burke, D. Adams, G. A. Laine et al., Impact of cardiopulmonary bypass and cardioplegic arrest on myocardial lymphatic function, Am J Physiol, vol.268, issue.1, pp.178-183, 1995.

B. Witzenbichler, T. Asahara, T. Murohara, M. Silver, I. Spyridopoulos et al., Vascular endothelial growth factor-C (VEGF-C/VEGF-2) promotes angiogenesis in the setting of tissue ischemia, Am J Pathol, vol.153, issue.10, pp.65582-65586, 1998.

D. W. Losordo, P. R. Vale, R. C. Hendel, C. E. Milliken, F. D. Fortuin et al., Phase ½ placebo-controlled, double-blind, dose-escalating trial of myocardial vascular endothelial growth factor 2 gene transfer by catheter delivery in patients with chronic myocardial ischemia, Circulation, vol.105, pp.2012-2018, 2002.

V. Joukov, T. Sorsa, V. Kumar, M. Jeltsch, L. Claesson-welsh et al., Proteolytic processing regulates receptor specificity and activity of VEGF-C, EMBO J, vol.16, pp.3898-3911, 1997.

Y. Cao, P. Linden, J. Farnebo, R. Cao, A. Eriksson et al., Vascular endothelial growth factor C induces angiogenesis in vivo, Proc Natl Acad Sci U S A, vol.95, pp.14389-14394, 1998.

R. Cao, A. Eriksson, H. Kubo, K. Alitalo, Y. Cao et al., Comparative evaluation of FGF-2-, VEGF-A-, and VEGF-C-induced angiogenesis, lymphangiogenesis, vascular fenestrations, and permeability, Circ Res, vol.94, pp.664-670, 2004.

T. Tammela, A. Saaristo, T. Holopainen, J. Lyytikkä, A. Kotronen et al., Therapeutic differentiation and maturation of lymphatic vessels after lymph node dissection and transplantation, Nat Med, vol.13, pp.1458-1466, 2007.

J. A. Nagy, E. Vasile, D. Feng, C. Sundberg, L. F. Brown et al., Vascular permeability factor/vascular endothelial growth factor induces lymphangiogenesis as well as angiogenesis, J Exp Med, vol.196, pp.1497-1506, 2002.

Y. Cao, Therapeutic angiogenesis for ischemic disorders: what is missing for clinical benefits, Discov Med, vol.9, pp.179-184, 2010.

R. Cao, H. Ji, N. Feng, Y. Zhang, X. Yang et al., Collaborative interplay between FGF-2 and VEGF-C promotes lymphangiogenesis and metastasis, Proc Natl Acad Sci U S A, vol.109, pp.15894-15899, 2012.